Delivery Order SPE2DB22D9316-SPE2DB26FYM50
- Not listed
- The Defense Logistics Agency awarded a $10,042.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 250 microgram vials of Nplate. The delivery order, issued May 12, 2025, with completion targeted for June 3, 2025, carries no set-aside designation. DMS Pharmaceutical Group leverages its position as a woman-owned small business to compete in federal procurement while fulfilling this...
- The Defense Logistics Agency awarded a delivery order valued at $1,673.67 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a pharmaceutical supply requirement to support Department of Defense healthcare operations. The award was made without a set-aside designation, and the products will be delivered to Park Ridge, Illinois, where the...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $21,874.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NPLATE 250 MCG VIALS, with a performance period ending on May 14, 2024. This delivery order is part of a larger single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with DLA, valued at up to $499,999,999,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of NPLATE 250 MCG VIALS. The contract, valued at $10,167.36, has an ultimate completion date of June 20, 2024 and was awarded on May 29, 2024. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of pharmaceutical products and medical supplies to the U.S. federal...
- The Defense Logistics Agency awarded a $25,111 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and requires performance at the contractor's Park Ridge facility. The award carries no set-aside designation, indicating the contractor...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. This $1,673.67 firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,736.70 by the Defense Logistics Agency on October 20, 2025, for the supply of Nplate 250 mcg vials. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,945.60 firm fixed-price contract is for the delivery of NPLATE 250 MCG VIALS, a specialized pharmaceutical product, with a completion date of June 24, 2024. This order is placed under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,389.12 firm fixed-price delivery order is for the supply of NPLATE 250 MCG VIALS, a pharmaceutical product, with a period of performance through November 5, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a $6,697.06 delivery order to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Nplate 500 microgram vials, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply fulfillment for federal healthcare needs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB26FYM50Delivery Order
The Defense Logistics Agency awarded a $10,042.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NPLATE 250 micrograms vials. The delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for supplying pharmaceuticals to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its established small business status and extensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The contractor's IDC under PPV-G GEN V, designated contract SPE2DR with a $499,999,999 ceiling value and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for recurring pharmaceutical supply needs. The company's demonstrated performance on numerous prior delivery orders and its registration in the System for Award Management since July 2001 establish its capability to fulfill the specialized pharmaceutical requirements supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 11/3/25 |